Evidence map›Paper›PMID 33898938›Full record

ArticleJAMIA open2021

Annotation and initial evaluation of a large annotated German oncological corpus.

Madeleine Kittner, Mario Lamping, Damian T Rieke, Julian Götze, Bariya Bajwa, Ivan Jelas, Gina Rüter, Hanjo Hautow, Mario Sänger, Maryam Habibi and 9 more

Open access · goldAbstract read
In one paragraph

Article in JAMIA open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 38 citations in OpenAlex.

  1. Article
  2. Article
  3. Cross- & multi-lingual medication detection: a transformer-based analysis.BMC medical informatics and decision making · 2025
    Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. BELB: a biomedical entity linking benchmark.Bioinformatics (Oxford, England) · 2023
    Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 5 institutions in 1 country.

Madeleine KittnerKnowledge Management for Bioinformatics, Humboldt Universität zu Berlin, Berlin, Germany.
Mario LampingDepartment of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Damian T RiekeDepartment of Hematology, Oncology and Cancer Immunology, Campus Benjamin Franklin, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Julian GötzeInnere Medizin I, Universitätsklinikum Tübingen, Tübingen, Germany.
Bariya BajwaInnere Medizin I, Universitätsklinikum Tübingen, Tübingen, Germany.
Ivan JelasCharité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Gina RüterCharité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Hanjo HautowKnowledge Management for Bioinformatics, Humboldt Universität zu Berlin, Berlin, Germany.
Mario SängerKnowledge Management for Bioinformatics, Humboldt Universität zu Berlin, Berlin, Germany.
Maryam HabibiKnowledge Management for Bioinformatics, Humboldt Universität zu Berlin, Berlin, Germany.
Marit ZettwitzCharité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Till de BortoliCharité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Leonie OstermannInnere Medizin I, Universitätsklinikum Tübingen, Tübingen, Germany.
Jurica ŠevaKnowledge Management for Bioinformatics, Humboldt Universität zu Berlin, Berlin, Germany.
Johannes StarlingerKnowledge Management for Bioinformatics, Humboldt Universität zu Berlin, Berlin, Germany.
Oliver KohlbacherInstitut für Translationale Bioinformatik, Universitätsklinikum Tübingen, Tübingen, Germany.
Nisar P MalekInnere Medizin I, Universitätsklinikum Tübingen, Tübingen, Germany.
Ulrich KeilholzCharité Comprehensive Cancer Center, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Berlin, Germany.
Ulf LeserKnowledge Management for Bioinformatics, Humboldt Universität zu Berlin, Berlin, Germany.
Humboldt-Universität zu Berlin · DEFreie Universität Berlin · DEUniversitätsklinikum Tübingen · DECharité - Universitätsmedizin Berlin · DEUniversity of Tübingen · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveWe present the Berlin-Tübingen-Oncology corpus (BRONCO), a large and freely available corpus of shuffled sentences from German oncological discharge summaries annotated with diagnosis, treatments, medications, and further attributes including negation and speculation. The aim of BRONCO is to foster reproducible and openly available research on Information Extraction from German medical texts. MATERIALS AND

methodsBRONCO consists of 200 manually deidentified discharge summaries of cancer patients. Annotation followed a structured and quality-controlled process involving 2 groups of medical experts to ensure consistency, comprehensiveness, and high quality of annotations. We present results of several state-of-the-art techniques for different IE tasks as baselines for subsequent research.

resultsThe annotated corpus consists of 11 434 sentences and 89 942 tokens, annotated with 11 124 annotations for medical entities and 3118 annotations of related attributes. We publish 75% of the corpus as a set of shuffled sentences, and keep 25% as held-out data set for unbiased evaluation of future IE tools. On this held-out dataset, our baselines reach depending on the specific entity types F1-scores of 0.72-0.90 for named entity recognition, 0.10-0.68 for entity normalization, 0.55 for negation detection, and 0.33 for speculation detection. DISCUSSION: Medical corpus annotation is a complex and time-consuming task. This makes sharing of such resources even more important.

conclusionTo our knowledge, BRONCO is the first sizable and freely available German medical corpus. Our baseline results show that more research efforts are necessary to lift the quality of information extraction in German medical texts to the level already possible for English.

Indexed as

corpus annotationGerman languagemedical information extraction

Identifiers

PMID33898938
PMCPMC8054032
OpenAlexW3156308192

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.